文章基本信息

标题：Impact of modified albumin–bilirubin grade on survival in patients with HCC who received lenvatinib
本地全文：下载
作者：Toshifumi Tada ; Takashi Kumada ; Atsushi Hiraoka 等
期刊名称：Scientific Reports
电子版ISSN：2045-2322
出版年度：2021
卷号：11
DOI：10.1038/s41598-021-93794-5
语种：English
出版社：Springer Nature
摘要：We investigated the impact on survival of modified albumin–bilirubin (mALBI) grade versus Child–Pugh classification in patients with hepatocellular carcinoma (HCC) who received lenvatinib. A total of 524 patients with HCC who received lenvatinib were included. Univariate analysis showed that mALBI grade 2b/3 and Child–Pugh class B/C were significantly associated with survival [hazard ratio (HR), 2.471; 95% confidence interval (CI), 1.944–3.141 and HR, 2.178; 95%CI, 1.591–2.982